The "Rabbit Syndrome" described by Villeneuve (1972) as a late-onset neuroleptic-induced extrapyromidal syndrome, is characterised by rhythmic 5-5.5 per second involuntary movements of the oral and masticatory musculature that mimic the chewing movements of a rabbit. The rabbit syndrome is readily reversible with the discontinuation of neuroleptics (Villeneuve, 1972) and responds to antiparkinsonian drugs (Sovner and Dimascio, 1977 ; Jus et al., 1979) . There are reports that the Rabbit syndrome persists in stage I NREM sleep unlike tardive dyskinesia, another late-onset neuroleptic-induced movement disorder Villeunve et al., 1973) .
Mr. S. R. a 38 year old unmarried male, consulted us on September 1980 with a recent onset of movement disorder confining to jaw and lips. He was attending out-patient department of National Institute of Mental Health and Neuro Sciences, Bangalore from 1967 onwards after an acute psychotic episode and had been on antipsychotic medication as suggested to him from time to time. He had no past history of any significant physical illness.
In 1967 he was treated with chlorpromazine (300-500 mgm/day) and improved over a period of three months. He resumed his occupation and was drug-free until 1973, when he developed a relapse of the psychotic illness with predominant schizophrenic features. He was treated with Chlorpromazine (300 mgm/day) and trifluperazine (15 mgm/day) and a course of 5 ECTS. Trihexyphenidyl (6 mgm/day) was added as he developed parkinsonian symptoms. Patient made a good social recovery and was maintained on the same drugs for a period of one year.
He was alright till 1976 when he again developed florid schizophrenic features and had to be hospitalized. He was treated with trifluperazine (30 mgm/day) and Chlorpromazine (100 mgm/day), and with a course of 6 ECTS. During his stay in hospital trihexyphenidyl (6 mgm/day) was added, as he developed parkinsonian symptoms. After discharge oral medications were gradually withdrawn and he was stabilized on fortnightly parenteral fluphenazine deconoate (25 mgm) and oral trihexyphenidyl (4 mgm/day).
He was maintaining good improvement and was on regular medications for four years. During this period, he had an exacerbation of psychotic symptoms and was prescribed haloperidol (15 mgm/day) in addition to the parenteral fluphenazine deconoate he had received a week earlier. It was six days after starting haloperidol, that he developed this movement disorder, for which consultation was sought.
At the time of evaluation, his mental status did not reveal any overt psychotic features. On physical examination he had an involuntary movement disorder which confined bilaterally to the oral and masticatory musculature.
The tongue was not involved. The movement was rhythmic and more at rest with a tendency to diminish while engaged in conversation. There were no other neurological abnormalities. The movement disorder was thought to be a recent onset tardive dyskinesia and he was admitted for detailed evaluation and treatment. Patient continued to receive haloperidol in the ward. On the second day of admission the patient had developed rigidity, tremors and bradykinesia in addition to these masticatory movements. He was given promethazine (50 mg) parenteral and within 45 minutes the parkinsonian symptoms and these masticatory movements disappeared completely. However the masticatory movement as such reappeared on the next day. At this stage a revised diagnosis of Rabbit syndrome was made as it fulfilled the clinical criteria. On the third day all drugs were withdrawn to facilitate a drug-free sleep EEG record.
The sleep EEG was recorded with a muscle electrode over the jaw.
The jaw movements were rhythmic with a frequency of six per second ( fig. 1 ). It was also seen that the movement disorder was not constantly present in Stage I NREM sleep. There were occasions when the movement was totally absent during this stage of sleep and this disappearance was patchy with no prediliction for early, middle or late parts of this stage of sleep. From the fifth day of admission trihexyphenedyl (8 mgm per day) was started and the movement disorder disappeared totally. He was discharged by the tenth day. He continued to remain symptom free on further weekly follow-ups without antipsychotics.
Trihexyphenedyl was withdrawn over a period of four weeks, and the movements did not reappear.
COMMENTS
The clinical description of this case is in keeping with the earlier description of Rabbit syndrome, including its response to antiparkinsonian drugs (Villenuve, 1972 ; Sovner and Dimascio, 1977 ; Jus et al., 1979) . As the movement did not persist throughout the stage I NREM sleep a differentiation from tardive dyskinesia needs to be made at a clinical level. Unlike Rabbit syndrome the initial movements of orofacial tardive dyskinesia occur in tongue and later spread to other parts (Ayd, 1967) . Also tardive dyskinesia tends to worsen on withdrawal of neuroleptics and might even be suppressed by antipsychotics (Baldessarini and Tarsy, 1975) . Even though its early symptoms are completely reversible (Quitkin et al., 1977) , tardive dyskinesia worsening with anticholingergic atniparkinsonian drugs is well emphasised (Baldessarini and Tarsy, 1975) . The latter feature certainly differentiates Rabbit syndrome from tardive dyskinesia, as the former specifially improves with antiparkinsonian drugs.
We maintain the view that the pathophysiology of Rabbit syndrome is similar to that of the drug induced parkinsonism . The coexistance of the drug-induced parkinsonism and improvement in both with antiparkinsonian drugs, as in this case substantiates this view. It is interesting to note that unlike druginduced parkinsonism Rabbit syndrome occurs as a late-onset neuroleptic induced movement disorder. Hence a separate terminology may be still valid.
